Malignant pleural mesothelioma.
Rao D P, Vijayan S, Vananjakar SS, T PK.
BMJ Case Rep. 2025 Feb 13;18(2):e263562. doi: 10.1136/bcr-2024-263562.
Asbestos-associated pulmonary disease.
Caceres JD, Venkata AN.
Curr Opin Pulm Med. 2023 Mar 1;29(2):76-82. doi: 10.1097/MCP.0000000000000939. Epub 2023 Jan 11.
Malignant pleural mesothelioma in situ.
Ando K, Morohoshi T, Tsuura Y, Masuda M.
Interact Cardiovasc Thorac Surg. 2022 Oct 10;35(5):ivac255. doi: 10.1093/icvts/ivac255.
Malignant Pleural Mesothelioma.
Bois MC, Lee HE, Erickson LA.
Mayo Clin Proc. 2016 Jul;91(7):e103-4. doi: 10.1016/j.mayocp.2016.02.019.
[Malignant pleural mesothelioma].
Sritharan SS, Frandsen JL, Omland Ø, Bruun JM.
Ugeskr Laeger. 2018 Apr 9;180(15):V06170439.
Malignant pleural mesothelioma: new guidelines make us stronger for defeating this disease.
Remon J, Hendriks LEL, Bironzo P.
Ann Oncol. 2022 Feb;33(2):123-125. doi: 10.1016/j.annonc.2021.11.019. Epub 2021 Dec 6.
Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy.
Porta C, Jean D, Blanquart C.
Front Immunol. 2023 Jul 24;14:1251384. doi: 10.3389/fimmu.2023.1251384. eCollection 2023.
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up( ).
Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2022 Feb;33(2):129-142. doi: 10.1016/j.annonc.2021.11.005. Epub 2021 Nov 30.
Multimodality treatment of malignant pleural mesothelioma: evolving patient selection criteria using scores.
Bölükbas S, Baldes N, Hoda MA, Eberlein M.
Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac153. doi: 10.1093/ejcts/ezac153.
Malignant Pleural Effusion in Malignant Pleural Mesothelioma: An Innocent Bystander?
Muruganandan S, Duong V.
Chest. 2021 Nov;160(5):1602-1603. doi: 10.1016/j.chest.2021.06.074.
